Heron Therapeutics Statistics
NASDAQ: HRTXHealthcareBiotechnologyUSD
0.3582-0.0261 (-6.79%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Heron Therapeutics by the numbers
Heron Therapeutics has a market capitalization of $68.0 million based on 189.85M shares outstanding. With trailing EPS of $-0.18, Heron Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.1% above its 50-day average and 54.1% below its 200-day average.
Average daily trading volume is 2.59M shares, or about $927,685 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HRTX valuation vs. peer median
| Metric | HRTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $68.01M | $68.34M | -0% |
| Avg. volume | 2.59M | 462.39K | +460% |
Peer median across 8 companies: HYFT, XBIT, CSBR, TENX, SPRO, RNTX, FBIO, GANX.
Valuation
- Market cap
- $68.01M
- EPS (TTM)
- $-0.18
- Shares outstanding
- 189.85M
Price and trading
- Previous close
- 0.3843
- Open
- 0.373
- Day range
- 0.3546 – 0.38
- 52-week range
- 0.26 – 1.58
- 52-week change
- -73.47%
- 50-day moving average
- 0.3474
- 200-day moving average
- 0.7799
- Beta
- —
- Volume
- 1.89M
- Average volume
- 2.59M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 68.01M
- Forward Pe
- -3.26
- Eps
- -0.18
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.58
- Week52 Low
- 0.26
- Avg Volume
- 2.59M
- Shares Outstanding
- 189.85M
- Ma50
- 0.35
- Ma200
- 0.78
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -77.33%
- Pct From52w Low
- 37.77%